Quadrant Capital Group LLC Exact Sciences Corp Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 923 shares of EXAS stock, worth $53,054. This represents 0.0% of its overall portfolio holdings.

Number of Shares
923
Previous 779 18.49%
Holding current value
$53,054
Previous $32,000 93.75%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$42.43 - $70.83 $6,109 - $10,199
144 Added 18.49%
923 $62,000
Q2 2024

Aug 12, 2024
SELL
$41.33 - $74.26 $9,381 - $16,857
-227 Reduced 22.56%
779 $32,000
Q1 2024

May 15, 2024
SELL
$56.27 - $73.77 $12,604 - $16,524
-224 Reduced 18.21%
1,006 $69,000
Q4 2023

Feb 08, 2024
BUY
$59.06 - $75.72 $19,489 - $24,987
330 Added 36.67%
1,230 $90,000
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $263 - $396
-4 Reduced 0.44%
900 $61,000
Q2 2023

Aug 09, 2023
BUY
$62.68 - $95.05 $250 - $380
4 Added 0.44%
904 $84,000
Q1 2023

May 11, 2023
BUY
$47.19 - $70.77 $1,462 - $2,193
31 Added 3.57%
900 $61,000
Q4 2022

Feb 10, 2023
BUY
$30.35 - $53.15 $1,578 - $2,763
52 Added 6.36%
869 $43,000
Q3 2022

Nov 10, 2022
BUY
$31.97 - $49.37 $2,717 - $4,196
85 Added 11.61%
817 $27,000
Q2 2022

Aug 09, 2022
SELL
$35.61 - $76.23 $8,297 - $17,761
-233 Reduced 24.15%
732 $29,000
Q1 2022

May 06, 2022
SELL
$57.56 - $82.54 $20,146 - $28,889
-350 Reduced 26.62%
965 $67,000
Q4 2021

Feb 01, 2022
BUY
$72.5 - $100.68 $18,342 - $25,472
253 Added 23.82%
1,315 $102,000
Q3 2021

Nov 12, 2021
BUY
$90.24 - $124.05 $13,445 - $18,483
149 Added 16.32%
1,062 $101,000
Q2 2021

Aug 09, 2021
SELL
$93.66 - $139.27 $2,809 - $4,178
-30 Reduced 3.18%
913 $113,000
Q1 2021

May 12, 2021
BUY
$116.57 - $155.01 $5,595 - $7,440
48 Added 5.36%
943 $124,000
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $7,371 - $10,516
74 Added 9.01%
895 $119,000
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $34,782 - $48,658
-477 Reduced 36.75%
821 $84,000
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $28,432 - $47,302
510 Added 64.72%
1,298 $113,000
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $2,577 - $7,101
-68 Reduced 7.94%
788 $46,000
Q4 2019

Feb 03, 2020
SELL
$77.66 - $99.74 $24,462 - $31,418
-315 Reduced 26.9%
856 $77,000
Q3 2019

Oct 24, 2019
BUY
$90.37 - $122.49 $1,084 - $1,469
12 Added 1.04%
1,171 $103,000
Q1 2019

Apr 29, 2019
BUY
$61.98 - $96.5 $34,274 - $53,364
553 Added 91.25%
1,159 $98,000
Q4 2018

Jan 17, 2019
BUY
$56.04 - $82.66 $504 - $743
9 Added 1.51%
606 $37,000
Q2 2017

Aug 15, 2017
BUY
N/A
597
597 $21,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email